Lipid profile good for new agent.
D017322:Clinical Trials, Phase II as Topic; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D009930:Organic Chemicals / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium
D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium